Showing results (1141-1150 of 9,978) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|March 2, 2019
Histological findings in patients with suspected mediastinal lymphoma relapse according to positive positron emission tomography scan during follow-up: a large retrospective analysis in 96 patientsAlessandro Broccoli, Sergio Nicola Forti Parri, Cinzia Pellegrini, et al.Leukemia & Lymphoma|November 9, 2018
A comparison of the efficacy of immunomodulatory-free regimens in relapsed or refractory multiple myeloma: a network meta-analysisKatja Weisel, Pieter Sonneveld, Andrew Spencer, et al.Leukemia & Lymphoma|November 9, 2018
Long-term effect of all-trans retinoic acid and arsenic trioxide sequential maintenance in patients with acute promyelocytic leukemiaShandong Tao, Chunling Wang, Yue Chen, et al.Leukemia & Lymphoma|November 9, 2018
Acute myeloid leukemia in the elderly: what constitutes treatment value?Chadi Nabhan, Siddhesh Kamat, Jonathan Karl KishLeukemia & Lymphoma|December 16, 2021
Treatment patterns, economic burden, and overall survival in US Medicare Advantage beneficiaries newly diagnosed with acute myeloid leukemia (AML) in 2015-2020Scott F Huntington, Michael P Ingham, Linda Okonkwo, et al.Leukemia & Lymphoma|November 11, 2021
Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center studySamantha N Reiss, Prakirthi Yerram, Lisa Modelevsky, et al.Leukemia & Lymphoma|July 31, 2019
Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are availableLynda Foltz, Gian-Matteo Pica, Hacene Zerazhi, et al.Leukemia & Lymphoma|March 8, 2021
lncRNA SNHG14 promotes oncogenesis and immune evasion in diffuse large-B-cell lymphoma by sequestering miR-152-3pYuyang Tian, Lianqiao Li, Guoqiang Lin, et al.Leukemia & Lymphoma|March 2, 2021
Tyrosine kinase inhibitor therapy discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States after clinical practice guideline updatesEhab L Atallah, Islam Sadek, Rodrigo Maegawa, et al.Leukemia & Lymphoma|April 13, 2017
Glucose-6-phosphate dehydrogenase deficiency and risk of invasive fungal disease in patients with acute myeloid leukemiaMarco Sanna, Giovanni Caocci, Antonio Ledda, et al.Pageof 998